Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01994876 |
Recruitment Status :
Completed
First Posted : November 26, 2013
Results First Posted : April 7, 2014
Last Update Posted : April 7, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ileostomy - Stoma | Device: Coloplast Test 1 Device: Coloplast Test 2 | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 18 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | November 2012 |
Actual Study Completion Date : | November 2012 |
Arm | Intervention/treatment |
---|---|
Experimental: First Coloplast Test 1
The subjects first test their own product to collect a baseline measurement The subjects are randomised to first test Coloplast Test 1 and thereafter Coloplast Test 2 |
Device: Coloplast Test 1
Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance Device: Coloplast Test 2 Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance |
Experimental: First Coloplast Test 2
The subjects first test their own product to collect baseline measurements The subjects are randomised to first test Coloplast Test 2 and thereafter Coloplast Test 1 |
Device: Coloplast Test 1
Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance Device: Coloplast Test 2 Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance |
- Degree of Leakage [ Time Frame: 14 days ]The degree of leakage was measured with a 32-point scale developed by Coloplast A/S, where 0 point represents the best possible outcome (no leakage) and 32 represents the worst possible outcome (full leakage under baseplate)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Subjects must comply with the following criteria in order to participate in the investigation:
- Are at least 18 years of age and have full legal capacity
- Have had an ileostomy for at least 3 months
- Have used a convex ostomy appliance for the last month
- Have given written informed consent
- Have an ileostomy with a diameter of 33 mm or less
- Have experience leakage (seeping) under the baseplate at least two times over the last two weeks
Exclusion Criteria:
Subjects complying with the following criteria must be excluded from participation in the clinical investigation:
- Have a loop ostomy (also called double-barrel or ostomy with two outlets)
- Are pregnant or breastfeeding
- Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy.
- Currently receiving or have received, within the last month, systemic or local steroid treatment (adreno-cortical hormone) in the peristomal area
- Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin))
- Are currently participating in another clinical investigation or has previously participated in this investigation

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01994876
Netherlands | |
QPS | |
Groningen, Netherlands, 9713 |
Principal Investigator: | Kalid S Abd-Elaziz, MD | QPS |
Responsible Party: | Coloplast A/S |
ClinicalTrials.gov Identifier: | NCT01994876 |
Other Study ID Numbers: |
CP229 |
First Posted: | November 26, 2013 Key Record Dates |
Results First Posted: | April 7, 2014 |
Last Update Posted: | April 7, 2014 |
Last Verified: | February 2014 |